Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
China
The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Nanjing Drum Tower Hospital, Nanjing, Jiangsu Shanghai East Hospital, Shanghai, Shanghai Municipality